D

Dare Bioscience
D

DARE

2.18500
USD
0.10
(4.80%)
مغلق
حجم التداول
7,873
الربح لكل سهم
-2
العائد الربحي
-
P/E
-13
حجم السوق
19,338,093
أصول ذات صلة
A
ACAD
0.820
(3.35%)
25.330 USD
I
IFRX
0.03810
(4.66%)
0.85650 USD
K
KALA
0.28000
(3.47%)
8.36000 USD
P
PRFX
-0.03500
(-2.48%)
1.37500 USD
S
STEM
0.280
(1.91%)
14.940 USD
المزيد
الأخبار المقالات

العنوان: Dare Bioscience Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatmentof bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.